Consolidated Statements of Cash Flows (Unaudited) (USD $)	9 Months Ended
	Sep. 30, 2012	Sep. 30, 2011
Cash Flows from Operating Activities:
Net loss	$ (7,239,978)	$ (3,225,880)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	210,556	349,295
Amortization of other intangible assets	193,070	214,299
Amortization of debt discount and debt issuance costs	68,976	84,277
Amortization of deferred rent	(24,552)	(59,491)
Impairment charge	3,397,212
Gain on debt restructuring	(1,048,308)
Interest expense forgiven on debt restructuring	140,667
Loss on sale of businesses		622
Loss on disposal of property and equipment	6,062	3,401
Increase in inventory reserve and inventory write downs	629,004	114,470
Stock-based compensation	44,313	291,759
(Increase) decrease in:
Trade accounts receivable, net	(30,166)	(145,709)
Inventories	1,011,366	(253,612)
Prepaid expenses	(27,141)	20,328
Other assets	25,959	8,847
Accounts payable, accrued liabilities and related party payable	(178,950)	280,413
Accrued compensation and benefits	(115,466)	6,300
Other liabilities	206	(3,369)
Total adjustments	4,302,808	911,830
Net cash used in operating activities	(2,937,170)	(2,314,050)
Cash Flows from Investing Activities:
Patents, trademark and other intangible assets costs	(83,076)	(134,321)
Purchase of property and equipment	(19,599)	(216,661)
Proceeds from the sale of property and equipment	7,685	7,500
Proceeds from the sale of businesses, net of transaction costs		1,110,360
Net cash (used in) provided by investing activities	(94,990)	766,878
Cash Flows from Financing Activities:
Proceeds from issuance of convertible preferred stock, net of issuance costs	5,195,225
Payment to restructure convertible promissory notes	(880,000)
Proceeds from exercise of employee stock options and warrants, net		319,750
Net cash provided by financing activities	4,315,225	319,750
Net increase (decrease) in Cash and Cash Equivalents	1,283,065	(1,227,422)
Cash and Cash Equivalents, beginning of period	3,014,656	5,308,900
Cash and Cash Equivalents, end of period	$ 4,297,721	$ 4,081,478